Primary Biliary Cholangitis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MIRM | D | Mirum Pharmaceuticals, Inc. | 0.98 | |
GNFT | F | GENFIT S.A. | 1.16 | |
THAR | F | Tharimmune, Inc. | 2.38 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Primary Biliary Cholangitis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | D | BioShares Biotechnology Products Fund | 1.44 | |
ILDR | C | First Trust Innovation Leaders ETF | 0.93 | |
XBI | D | SPDR S&P Biotech ETF | 0.78 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 0.77 | |
LABU | F | Direxion Daily S&P Biotech Bull 3X Shares | 0.57 |
Compare ETFs
Related Industries:
Biotechnology
- Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC) is a chronic, progressive autoimmune liver disease that affects the small bile ducts in the liver. It is caused by an immune system attack on the bile ducts, leading to inflammation, scarring, and eventual destruction of the ducts. Symptoms of PBC include fatigue, itching, jaundice, and abdominal pain. Treatment typically involves medications to reduce inflammation and slow the progression of the disease.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles